ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Implications of different cell death patterns for prognosis and immunity in lung adenocarcinoma

Zhou, Yang; Gao, Weitong; Xu, Yu; Wang, Jiale; Wang, Xueying; Shan, Liying; Du, Lijuan; Sun, Qingyu; Li, Hongyan; Liu, Fang*东北农业大学; 哈尔滨医科大学
npj Precision Oncology2023-11-15DOI: 10.1038/s41698-023-00456-y
24阅读
引用收藏
分享

摘要

In recent years, lung adenocarcinoma (LUAD) has become a focus of attention due to its low response to treatment, poor prognosis, and lack of reliable indicators to predict the progression or therapeutic effect of LUAD. Different cell death patterns play a crucial role in tumor development and are promising for predicting LUAD prognosis. From the TCGA and GEO databases, we obtained bulk transcriptomes, single-cell transcriptomes, and clinical information. Genes in 15 types of cell death were analyzed for cell death index (CDI) signature establishment. The CDI signature using necroptosis + immunologic cell death-related genes was established in the TCGA cohort with the 1-, 2-, 3-, 4- and 5-year AUC values were 0.772, 0.736, 0.723, 0.795, and 0.743, respectively. The prognosis was significantly better in the low CDI group than in the high CDI group. We also investigated the relationship between the CDI signature and clinical variables, published prognosis biomarkers, immune cell infiltration, functional enrichment pathways, and immunity biomarkers. In vitro assay showed that HNRNPF and FGF2 promoted lung cancer cell proliferation and migration and were also involved in cell death. Therefore, as a robust prognosis biomarker, CDI signatures can screen for patients who might benefit from immunotherapy and improve diagnostic accuracy and LUAD patient outcomes.

学科与关键词

关键词
CANCERVALIDATIONEXPRESSIONBLOCKADE
相关
加载中…
  • Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma
    Zhou, Xiang; Xu, Ran; Lu, Tong; Wang, Chenghao; Chang, Xiaoyan; Peng, Bo; Shen, Zhiping; Yao, Lingqi; Wang, Kaiyu; Xu, Chengyu; Shi, Jiaxin; Zhang, Ren; Zhao, Jiaying; Zhang, Linyou*Scientific Reports, 2023, 13(1).
  • A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma
    Chen, Zi; Ge, Linyang; Xu, Shuanglan; Li, Qin*; Zhou, Linfu*Scientific Reports, 2023, 13(1): 9921.
  • Identification of necroptosis-related signature and tumor microenvironment infiltration characteristics in lung adenocarcinoma
    Liu, Taisheng; Guo, Liyi; Liu, Guihong; Dai, Zili; Wang, Li; Lin, Baisheng; Hu, Xiaoshan; Wang, Jian; Zhang, Jian*Lung Cancer, 2022, 172: 75-85.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
npj Precision Oncology
发表日期
2023-11-15
卷期
第 7 卷, 第 1 期
页码
121
DOI
10.1038/s41698-023-00456-y
成果收录
SCIE
资助标注
This study was supported by the Haiyan Foundation of Harbin Medical University Cancer Hospital (grant number: 91339107), the Beijing Health Alliance Charitable Foundation (grant number: 31471095), the National Cancer Centre Climbing Foundation (grant numbe [91339107]; Haiyan Foundation of Harbin Medical University Cancer Hospital [31471095]; Beijing Health Alliance Charitable Foundation [NCC201908B11]; National Cancer Centre Climbing Foundation [81270113]; Beijing Science and Technology Innovation Medical Development Foundation

作者

  • Z

    Zhou, Yang (第一作者)

    harbin med univ

  • G

    Gao, Weitong

    harbin med univ

查看全部 10 位作者收起作者
  • X

    Xu, Yu

    northeast agr univ

  • W

    Wang, Jiale

    harbin med univ

  • W

    Wang, Xueying

  • S

    Shan, Liying

    harbin med univ

  • D

    Du, Lijuan

    harbin med univ

  • S

    Sun, Qingyu

    harbin med univ

  • L

    Li, Hongyan

    harbin med univ

  • L

    Liu, Fang (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417